Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Planning and Analysis of Axon Degeneration Screening Experiments.

Methods in molecular biology (Clifton, N.J.) - 1 Jan 2020

Lovell Lyndah, Bramley John, Buchser William

Abstract excerpt

A network of intersecting molecular pathways interacts to initiate and execute axon destruction. Maximum protection against axon degeneration likely requires more than manipulation of a single target. Here, we describe the process of designing a high-throughput arrayed screening assay for the identification of key factors responsible for axon destruction and/or protection. First, we go over some existing screens...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Combinatorial Chemistry Techniques
Share to Drug Evaluation, Preclinical

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Finches

Share to High-Throughput Screening Assays

Share to Nerve Degeneration

Share to Quality Control

Share to Retinal Ganglion Cells

Share to Support Vector Machine

Source

Identifiers

PMID: 32524473
DOI: 10.1007/978-1-0716-0585-1_6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Planning and Analysis of Axon Degeneration Screening Experiments.PMID 32524473Read ↗

Phenotypic screening with primary neurons to identify drug targets for regeneration and degeneration.Semantic proximity Read ↗

Programmed axon degeneration: from mouse to mechanism to medicineSemantic proximity Read ↗

A Systematic Approach to Identify Neuroprotective Interventions for Motor Neuron DiseaseSemantic proximity Read ↗

Therapeutic opportunities and pitfalls in the treatment of axon degenerationSemantic proximity Read ↗

Automated in vivo drug screen in zebrafish identifies synapse-stabilising drugs with relevance to spinal muscular atrophy.Semantic proximity Read ↗

Exploring SARM1 as a target to delay programmed axon degenerationSemantic proximity Read ↗

Axon pathology in neurological disease: a neglected therapeutic target.Semantic proximity Read ↗

Systemic loss of Sarm1 protects Schwann cells from chemotoxicity by delaying axon degeneration.Semantic proximity Read ↗

Axon Death Pathways Converge on Axundead to Promote Functional and Structural Axon DisassemblySemantic proximity Read ↗

High-content phenotypic screening and triaging strategy to identify small molecules driving oligodendrocyte progenitor cell differentiation.Semantic proximity Read ↗

Phenotypic Screening of Small-Molecule Inhibitors: Implications for Therapeutic Discovery and Drug Target Development in Traumatic Brain Injury.Semantic proximity Read ↗

Defining the Neural Kinome: Strategies and Opportunities for Small Molecule Drug Discovery to Target Neurodegenerative DiseasesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.